The voltage-gated Kv1.3 potassium channel has gained interest as a therapeutic target for obesity, as mice lacking Kv1.3 or treated with a Kv1.3 blocker are protected from high-fat diet (HFD)-induced obesity [19, 20]. The gene discussed is KCNA3; the disease is obesity disorder.